| Gene symbol | NRARP | Synonyms | None | Type of gene | protein-coding |
| Chromosome | 9 | Map location | 9q34.3 | dbXrefs | |
| Description | NOTCH regulated ankyrin repeat protein | ||||
| GTO ID | GTC3258 |
| Trial ID | NCT05637255 |
| Disease | Age-Related Macular Degeneration | Macular Degeneration |
| Altered gene | NRARP |
| Therapeutic/Target gene | Target gene |
| Therapy | siRNA |
| Treatment | SYL1801 |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular AMD |
| Year | 2022 |
| Country | Czechia|Poland|Slovakia |
| Company sponsor | Sylentis, S.A. |
| Other ID(s) | SYL1801_II|2022-000214-34 |
| Cohort1: Low Dose | |||||||||
|
|||||||||
| Cohort2: Middle Dose | |||||||||
|
|||||||||
| Cohort3: High Dose | |||||||||
|
|||||||||